The Scientist

» FDA and developmental biology

Most Recent

image: Contributors

Contributors

By | April 1, 2015

Meet some of the people featured in the April 2015 issue of The Scientist.

0 Comments

image: From Many, One

From Many, One

By | April 1, 2015

Diverse mammals, including humans, have been found to carry distinct genomes in their cells. What does such genetic chimerism mean for health and disease?

4 Comments

image: Short, Strong Signals

Short, Strong Signals

By | March 25, 2015

Methylation increases both the activity and instability of the signaling protein Notch.

0 Comments

image: FDA Deems GM Apples, Potatoes Safe

FDA Deems GM Apples, Potatoes Safe

By | March 23, 2015

Genetically modified, non-browning apples and bruise-resistant potatoes are safe, the US Food and Drug Administration says.

0 Comments

image: FDA OKs First Biosimilar

FDA OKs First Biosimilar

By | March 6, 2015

The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.

2 Comments

image: HHS Rolls Out Public Access Plans

HHS Rolls Out Public Access Plans

By | March 3, 2015

The US Department of Health and Human Services outlines how the National Institutes of Health and its other agencies will make research results public.

0 Comments

image: FDA OKs 23andMe Test

FDA OKs 23andMe Test

By | February 20, 2015

The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.

0 Comments

image: Clinic Trial Problems Kept Mum

Clinic Trial Problems Kept Mum

By | February 11, 2015

Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.

0 Comments

image: FDA Head Leaving Post

FDA Head Leaving Post

By | February 6, 2015

US Food and Drug Administration commissioner Margaret Hamburg is stepping down after six years on the job.

0 Comments

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

Popular Now

  1. Next Generation: Nanotube Scaffolds Reconnect Spinal Neurons
  2. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  3. Will Organs-in-a-Dish Ever Replace Animal Models?
  4. Your Office Has a Distinct Microbiome
RayBiotech